search
Back to results

HMB and Exercise-induced Muscle Damage

Primary Purpose

Supplementation, Sport, Sports Nutrition

Status
Recruiting
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
HMB supplementation
Placebo treatment
Sponsored by
Poznan University of Physical Education
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Supplementation

Eligibility Criteria

18 Years - 35 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • written informed consent from all participants before the study
  • a current medical clearance to practice sports,
  • training experience: at least 1 year strength training programs that include lower limbs,
  • minimum of 3 workout sessions (strength/resistance training) a week,
  • protein intake in customary diet and during the study protocol > 1.6g / kg of body mass per day,
  • individual maximum strength greater than 2.5 times the body weight for the 1RM test in the leg-press.

Exclusion Criteria:

  • current injury,
  • any health-related contraindication,
  • declared general feeling of being unwell,
  • unwilling to follow the study protocol,
  • serious disease or metabolic problems,
  • intake of creatine, caffeine or beta-alanine, or other ergogenic supplements 3 months before the beginning of the study,
  • history of anabolic androgenic steroids or drugs use that may interfere with muscle mass control (eg, corticosteroids), or affect physical performance,
  • smoking and tobacco use,
  • presence of infectious disease in the previous 4 weeks of the study.

Sites / Locations

  • Escola de Educação Física e Esporte da USP / School of Physical Education and Sport - USP.Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

HMB supplementation

Placebo treatment

Arm Description

The experimental procedure for each participant in this group includes a one week HMB supplementation. HMB will be administered in the form of blinded capsules containing 0.5 g HMB per capsule. The capsules will be ingested with at least 250 mL of water. Each athlete will ingest 8 capsules (4 x 2 capsules) of HMB in a split dose per day. On training days the supplements will be taken in the morning (2 capsules), 1.5 hours before training session (2 capsules), immediately after training (2 capsules) and before sleep (2 capsules). On rest days the supplements will be taken in the morning (2 capsules), around midday (2 capsules), in the afternoon (2 capsules) and before bedtime (2 capsules) at possibly similar (approx. 4 hours) intervals during the day.

The experimental procedure for each participant in this group includes a one-week placebo (PLA) administration. PLA (corn starch) will be placed in the blinded capsules form. PLA will be ingested with at least 250 mL of water. Each participant in this group will ingest 8 placebo capsules a day. On training days the PLA capsules will be taken in the morning (2 capsules), 1.5 hours before training session (2 capsules), immediately after training (2 capsules) and before sleep (2 capsules). On rest days the supplements will be taken in the morning (2 capsules), around midday (2 capsules), in the afternoon (2 capsules) and before bedtime (2 capsules) at possibly similar (approx. 4 hours) intervals.

Outcomes

Primary Outcome Measures

Changes in the maximum voluntary isometric contraction (MVIC) after supplementation and exercises-induced muscle damage
Maximum voluntary isometric contraction (MVIC) torque (Nm)

Secondary Outcome Measures

Change in the histological sarcomere integrity (after biopsy of the vastus lateralis muscle samples) after supplementation and exercises-induced muscle damage
The disruption of the Z-line areas and the total visible fiber area in muscle fibers (%)
Change in the molecular potential (after biopsy of the vastus lateralis muscle samples) after supplementation and exercises-induced muscle damage
AKTser473, mTORSer2448, p70S7K1Thr389, 4E-BP1Ser65/Thr70, and 4EBP1Thr37/46 kinase activity (optical density)
Change in the muscle cholesterol and mevalonate content (in the vastus lateralis muscle samples) after supplementation and exercises-induced muscle damage
Muscle cholesterol and mevalonate content (units)
Changes in creatine kinase (CK) and lactate dehydrogenase (LDH) activity (IU) in blood after supplementation and exercises-induced muscle damage
CK and LDH activity (IU)
Change in the strength performance results (at 80% of the individual's 1RM) in three resistance exercises (squats, the leg press, and leg extension) before and after supplementation and exercises-induced muscle damage
Number of repetitions in each sets of squats, the leg press, and leg extension (reps)

Full Information

First Posted
September 8, 2020
Last Updated
March 2, 2022
Sponsor
Poznan University of Physical Education
Collaborators
Escola de Educação Física e Esporte da Universidade de São Paulo (Brazil) - Parallel sponsor of the research, National Science Centre, Poland
search

1. Study Identification

Unique Protocol Identification Number
NCT04549610
Brief Title
HMB and Exercise-induced Muscle Damage
Official Title
The Effect of β-hydroxy-β-methylbutyrate Supplementation on Muscle Damage Induced by Resistance Exercise
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 1, 2019 (Actual)
Primary Completion Date
December 1, 2022 (Anticipated)
Study Completion Date
January 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Poznan University of Physical Education
Collaborators
Escola de Educação Física e Esporte da Universidade de São Paulo (Brazil) - Parallel sponsor of the research, National Science Centre, Poland

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study aims at assessing the influence of β-hydroxy-β-methylbutyrate (HMB) supplementation (4.0 g/day) supplemented for 7 days in a group of speed-strength trained individuals on lower-body strength performance, selected muscle histological, molecular and blood markers of muscle recovery in response to resistance exercise-induced muscle damage.
Detailed Description
The main aim of the project is to assess the effects of seven days of HMB (4.0 g/day) or Placebo (PLA) supplementation on lower body strength performance, and functional, histological, clinical and molecular markers of muscle recovery after an acute resistance exercise session. The study is a double-blind, randomized, placebo-controlled, parallel trial. 30 male participants will be divided randomly into two parallel groups: One group receiving 4.0 g/day HMB and the second group receiving PLA. Supplementation period (HMB or PLA) will be seven days (five days before and two days after muscle damage induced by an acute resistance training session). Food intake during the intervention will be assessed with the use of a food diary. Before the start of the experimental protocol, the participants will be familiarized with all tests and procedures. During the first visit, participants will be assessed for their anthropometric characteristics, and baseline blood samples will be collected for the analysis of the activity of muscle damage markers [creatine kinase (CK) and lactate dehydrogenase (LDH)]. We will then carry out the evaluation of the maximal voluntary isometric contraction (MVIC; performed in a Biodex isokinetic dynamometer), lower body maximum dynamic strength (1RM) for squat, leg press, and leg extension exercises. The participants will then return to the laboratory to repeat the same tests and confirm the obtained results (MVIC and 1RM tests). On the third day, participants will take part in a resistance training session (RE3sets) to evaluate strength performance. We will monitor the maximum number of repetitions possible in three sets of three exercises (squats, the leg press, and leg extension), until the concentric failure, with a rest interval of two minutes per set. The workload will correspond to 80% of the individual's 1RM). Participants will then spend five to seven days without any leg strength/power training, in order to facilitate effective recovery prior to the next main resistance exercises training (RE5sets), which will be designed to induce muscle damage. Furthermore, HMB or PLA supplementation will commence five days before RE5sets, and continue for 48 hours after RE5sets. Before the RE5sets, a muscle biopsy will be done in the vastus lateralis for morphological analysis of the sarcomere integrity (histological analysis) and molecular testing (e.g. selected protein kinase activity (e.g. AKTser473, mTORSer2448, p70S7K1Thr389, 4E-BP1Ser65/Thr70, 4EBP1Thr37/46); muscle cholesterol, and mevalonate content). Blood samples will also be collected. After the biopsy, participants will carry out exercises similar to those performed in the preliminary studies, but will do 5 sets per exercise until concentric failure with a 2-min resting interval between sets and load corresponding to 80% of the participant's 1RM. 24 hours after the end of RE5sets, blood samples will be taken and the evaluation of the MVIC will be performed. 24 hours later (48 hours after the RE5sets), a muscle biopsy (for histological and molecular testing) will be conducted, and blood samples will be collected. Furthermore, the MVIC and RE3sets will also be measured. Collected data will be compared between groups and times using mixed models (proc mixed, SAS v.9.3) followed by multiple comparisons of a hypothesis-driven single degree of freedom contrast analysis. The sample size was estimated at 24 in total, assuming an intra- and inter-subject interaction model, alpha level of 5%, power (1-β) of 0.8 and effect size 0.3 (small) (G*Power v.3.9.1.2). We will recruit a slightly larger number of participants (n = 30) to allow for the likely dropouts that will occur throughout the study. The level of significance adopted will be p <0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Supplementation, Sport, Sports Nutrition, Muscle Damage, Recovery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
HMB supplementation
Arm Type
Experimental
Arm Description
The experimental procedure for each participant in this group includes a one week HMB supplementation. HMB will be administered in the form of blinded capsules containing 0.5 g HMB per capsule. The capsules will be ingested with at least 250 mL of water. Each athlete will ingest 8 capsules (4 x 2 capsules) of HMB in a split dose per day. On training days the supplements will be taken in the morning (2 capsules), 1.5 hours before training session (2 capsules), immediately after training (2 capsules) and before sleep (2 capsules). On rest days the supplements will be taken in the morning (2 capsules), around midday (2 capsules), in the afternoon (2 capsules) and before bedtime (2 capsules) at possibly similar (approx. 4 hours) intervals during the day.
Arm Title
Placebo treatment
Arm Type
Placebo Comparator
Arm Description
The experimental procedure for each participant in this group includes a one-week placebo (PLA) administration. PLA (corn starch) will be placed in the blinded capsules form. PLA will be ingested with at least 250 mL of water. Each participant in this group will ingest 8 placebo capsules a day. On training days the PLA capsules will be taken in the morning (2 capsules), 1.5 hours before training session (2 capsules), immediately after training (2 capsules) and before sleep (2 capsules). On rest days the supplements will be taken in the morning (2 capsules), around midday (2 capsules), in the afternoon (2 capsules) and before bedtime (2 capsules) at possibly similar (approx. 4 hours) intervals.
Intervention Type
Dietary Supplement
Intervention Name(s)
HMB supplementation
Intervention Description
Group taking oral HMB supplementation in a blinded capsule form.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo treatment
Intervention Description
Group taking oral supplementation with placebo (corn starch) in a blinded capsule form.
Primary Outcome Measure Information:
Title
Changes in the maximum voluntary isometric contraction (MVIC) after supplementation and exercises-induced muscle damage
Description
Maximum voluntary isometric contraction (MVIC) torque (Nm)
Time Frame
Baseline, 24 hours and 48 hours after the end of exercises-induced muscle damage
Secondary Outcome Measure Information:
Title
Change in the histological sarcomere integrity (after biopsy of the vastus lateralis muscle samples) after supplementation and exercises-induced muscle damage
Description
The disruption of the Z-line areas and the total visible fiber area in muscle fibers (%)
Time Frame
Baseline, 24 hours and 48 hours after the end of exercises-induced muscle damage
Title
Change in the molecular potential (after biopsy of the vastus lateralis muscle samples) after supplementation and exercises-induced muscle damage
Description
AKTser473, mTORSer2448, p70S7K1Thr389, 4E-BP1Ser65/Thr70, and 4EBP1Thr37/46 kinase activity (optical density)
Time Frame
Baseline, 24 hours and 48 hours after the end of exercises-induced muscle damage
Title
Change in the muscle cholesterol and mevalonate content (in the vastus lateralis muscle samples) after supplementation and exercises-induced muscle damage
Description
Muscle cholesterol and mevalonate content (units)
Time Frame
Baseline, 24 hours and 48 hours after the end of exercises-induced muscle damage
Title
Changes in creatine kinase (CK) and lactate dehydrogenase (LDH) activity (IU) in blood after supplementation and exercises-induced muscle damage
Description
CK and LDH activity (IU)
Time Frame
Baseline, 24 hours and 48 hours after the end of exercises-induced muscle damage
Title
Change in the strength performance results (at 80% of the individual's 1RM) in three resistance exercises (squats, the leg press, and leg extension) before and after supplementation and exercises-induced muscle damage
Description
Number of repetitions in each sets of squats, the leg press, and leg extension (reps)
Time Frame
Baseline and 48 hours after the end of exercises-induced muscle damage

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: written informed consent from all participants before the study a current medical clearance to practice sports, training experience: at least 1 year strength training programs that include lower limbs, minimum of 3 workout sessions (strength/resistance training) a week, protein intake in customary diet and during the study protocol > 1.6g / kg of body mass per day, individual maximum strength greater than 2.5 times the body weight for the 1RM test in the leg-press. Exclusion Criteria: current injury, any health-related contraindication, declared general feeling of being unwell, unwilling to follow the study protocol, serious disease or metabolic problems, intake of creatine, caffeine or beta-alanine, or other ergogenic supplements 3 months before the beginning of the study, history of anabolic androgenic steroids or drugs use that may interfere with muscle mass control (eg, corticosteroids), or affect physical performance, smoking and tobacco use, presence of infectious disease in the previous 4 weeks of the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Guilherme G Artioli, Prof., PhD
Phone
+55 11 3091-8783
Email
artioli@usp.br
First Name & Middle Initial & Last Name or Official Title & Degree
Krzysztof Durkalec-Michalski, Prof., PhD
Phone
+48 61 835 51 65
Email
durkalec-michalski@awf.poznan.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guilherme G Artioli, Prof., PhD
Organizational Affiliation
Applied Physiology & Nutrition Research Group, University of Sao Paulo. Sao Paulo, SP. Brazil.
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Krzysztof Durkalec-Michalski, Dr hab., PhD
Organizational Affiliation
Department of Sports Dietetics, Poznan University of Physical Education, Poznań, Poland
Official's Role
Principal Investigator
Facility Information:
Facility Name
Escola de Educação Física e Esporte da USP / School of Physical Education and Sport - USP.
City
São Paulo
State/Province
São Paulo - SP
ZIP/Postal Code
05508-030
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Guilherme G Artioli, Prof., PhD
Phone
+55 11 3091-8783
Email
artioli@usp.br
First Name & Middle Initial & Last Name & Degree
Krzysztof Durkalec-Michalski, Prof., PhD
First Name & Middle Initial & Last Name & Degree
Giovani B Custoias, BSc

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

HMB and Exercise-induced Muscle Damage

We'll reach out to this number within 24 hrs